About K36 Therapeutics
Targeting NSD2: Advancing Precision Medicine through Epigenetics.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cambridge, United States
Year Founded
2021
Team Size
1-10
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
k36tx.com
Domain Registered Date
Nov 12, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $70,000,000 · Series-B+
fundraisingfox.com
- Milestone
X account created (@k36tx)
40 followers
- Capital Raise
Raised $30,000,000 · Series-A
- Milestone
Company founded
Cambridge, United States
- Milestone
Website domain registered
k36tx.com
Investors & Backers
Atlas Venture
Bristol-Myers Squibb
Eight Roads Ventures
F-Prime Capital
Nextech Invest
Funding History
Series-B+
· Jun 28, 2023
$70,000,000 fundraisingfox.com
Series-A
· Dec 9, 2021
$30,000,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026